Warning: The NCBI web site requires JavaScript to function. more...

PubMed

US National Library of Medicine National Institutes of Health

RSS
RSS Settings
- Search: "Plésiat P"[Author]
- Number of items displayed:
- Feed name:
Save search
Advanced
Help

We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

<< First< Prev

Page of 5

Next >Last >>

Results: 1 to 20 of 100

Select item 236290141.

Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.

Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A; on behalf of the GERPA Study Group.

J Antimicrob Chemother. 2013 Apr 29. [Epub ahead of print]

PMID:: 23629014; [PubMed - as supplied by publisher]

Related citations

Select item 235876542.

Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.

Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K.

J Antimicrob Chemother. 2013 Apr 14. [Epub ahead of print]

PMID:: 23587654; [PubMed - as supplied by publisher]

Related citations

Select item 235575393.

Difficult-to-detect carbapenem-resistant IMP13-producing P. aeruginosa: experience feedback concerning a cluster of urinary tract infections at a surgical clinic in France.

Milan O, Debroize L, Bertrand X, Plesiat P, Valentin AS, Quentin R, Van der Mee-Marquet N.

Antimicrob Resist Infect Control. 2013 Apr 4;2(1):12. doi: 10.1186/2047-2994-2-12.

PMID:: 23557539; [PubMed]

Free PMC Article

Related citations

Select item 234336084.

Alternatives to carbapenems in ESBL-producing Escherichia coli infections.

Fournier D, Chirouze C, Leroy J, Cholley P, Talon D, Plésiat P, Bertrand X.

Med Mal Infect. 2013 Feb;43(2):62-6. doi: 10.1016/j.medmal.2013.01.006. Epub 2013 Feb 19.

PMID:: 23433608; [PubMed - in process]

Related citations

Select item 233187965.

Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.

Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppé E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plésiat P, Andremont A.

Antimicrob Agents Chemother. 2013 Mar;57(3):1488-95. doi: 10.1128/AAC.01823-12. Epub 2013 Jan 14.

PMID:: 23318796; [PubMed - in process]

Related citations

Select item 232413796.

Clonal dissemination of Pseudomonas aeruginosa isolates producing extended-spectrum β-lactamase SHV-2a.

Jeannot K, Fournier D, Müller E, Cholley P, Plésiat P.

J Clin Microbiol. 2013 Feb;51(2):673-5. doi: 10.1128/JCM.02313-12. Epub 2012 Dec 12.

PMID:: 23241379; [PubMed - in process]

Related citations

Select item 232094207.

Unique biofilm signature, drug susceptibility and decreased virulence in Drosophila through the Pseudomonas aeruginosa two-component system PprAB.

de Bentzmann S, Giraud C, Bernard CS, Calderon V, Ewald F, Plésiat P, Nguyen C, Grunwald D, Attree I, Jeannot K, Fauvarque MO, Bordi C.

PLoS Pathog. 2012;8(11):e1003052. doi: 10.1371/journal.ppat.1003052. Epub 2012 Nov 29. Erratum in: PLoS Pathog. 2012 Dec;8(12). doi: 10.1371/annotation/5c169544-7d19-40db-9a58-28b2fdf2c82c.

PMID:: 23209420; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 230890498.

Spread of the bla(IMP-13) gene in French Pseudomonas aeruginosa through sequence types ST621, ST308 and ST111.

Fournier D, Jeannot K, Robert-Nicoud M, Muller E, Cholley P, van der Mee-Marquet N, Plésiat P.

Int J Antimicrob Agents. 2012 Dec;40(6):571-3. doi: 10.1016/j.ijantimicag.2012.08.006. Epub 2012 Oct 23. No abstract available.

PMID:: 23089049; [PubMed - indexed for MEDLINE]

Related citations

Select item 227192599.

Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting.

Hocquet D, Llanes C, Thouverez M, Kulasekara HD, Bertrand X, Plésiat P, Mazel D, Miller SI.

PLoS Pathog. 2012;8(6):e1002778. doi: 10.1371/journal.ppat.1002778. Epub 2012 Jun 14.

PMID:: 22719259; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 2257385010.

Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.

Buyck JM, Plésiat P, Traore H, Vanderbist F, Tulkens PM, Van Bambeke F.

Clin Infect Dis. 2012 Aug;55(4):534-42. doi: 10.1093/cid/cis473. Epub 2012 May 9.

PMID:: 22573850; [PubMed - indexed for MEDLINE]

Related citations

Select item 2229096011.

IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa.

Jeannot K, Poirel L, Robert-Nicoud M, Cholley P, Nordmann P, Plésiat P.

Antimicrob Agents Chemother. 2012 Apr;56(4):2187-90. doi: 10.1128/AAC.05838-11. Epub 2012 Jan 30.

PMID:: 22290960; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 2221868312.

Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis.

Buyck JM, Guénard S, Plésiat P, Tulkens PM, Van Bambeke F.

J Antimicrob Chemother. 2012 Mar;67(3):771-5. doi: 10.1093/jac/dkr543. Epub 2012 Jan 3. No abstract available.

PMID:: 22218683; [PubMed - indexed for MEDLINE]

Free Article

Related citations

Select item 2198049313.

Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis.

Naudin C, Joulin-Giet A, Couetdic G, Plésiat P, Szymanska A, Gorna E, Gauthier F, Kasprzykowski F, Lecaille F, Lalmanach G.

PLoS One. 2011;6(9):e25577. doi: 10.1371/journal.pone.0025577. Epub 2011 Sep 28.

PMID:: 21980493; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 2191157414.

Role of the MexEF-OprN efflux system in low-level resistance of Pseudomonas aeruginosa to ciprofloxacin.

Llanes C, Köhler T, Patry I, Dehecq B, van Delden C, Plésiat P.

Antimicrob Agents Chemother. 2011 Dec;55(12):5676-84. doi: 10.1128/AAC.00101-11. Epub 2011 Sep 12.

PMID:: 21911574; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 2166590615.

Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa.

Hocquet D, Colomb M, Dehecq B, Belmonte O, Courvalin P, Plésiat P, Meziane-Cherif D.

J Antimicrob Chemother. 2011 Aug;66(8):1745-50. doi: 10.1093/jac/dkr187. Epub 2011 Jun 10.

PMID:: 21665906; [PubMed - indexed for MEDLINE]

Free Article

Related citations

Select item 2145095016.

Strain-tailored double-disk synergy test detects extended-spectrum oxacillinases in Pseudomonas aeruginosa.

Hocquet D, Dehecq B, Bertrand X, Plésiat P.

J Clin Microbiol. 2011 Jun;49(6):2262-5. doi: 10.1128/JCM.02585-10. Epub 2011 Mar 30.

PMID:: 21450950; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 2145000617.

The Pseudomonas aeruginosa opportunistic pathogen and human infections.

de Bentzmann S, Plésiat P.

Environ Microbiol. 2011 Jul;13(7):1655-65. doi: 10.1111/j.1462-2920.2011.02469.x. Epub 2011 Mar 30.

PMID:: 21450006; [PubMed - indexed for MEDLINE]

Related citations

Select item 2114961918.

A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.

Muller C, Plésiat P, Jeannot K.

Antimicrob Agents Chemother. 2011 Mar;55(3):1211-21. doi: 10.1128/AAC.01252-10. Epub 2010 Dec 13.

PMID:: 21149619; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

Select item 2069207019.

Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital.

Cholley P, Gbaguidi-Haore H, Bertrand X, Thouverez M, Plésiat P, Hocquet D, Talon D.

J Hosp Infect. 2010 Dec;76(4):316-9. doi: 10.1016/j.jhin.2010.06.007. Epub 2010 Aug 9.

PMID:: 20692070; [PubMed - indexed for MEDLINE]

Related citations

Select item 2054781420.

Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France.

Hocquet D, Plésiat P, Dehecq B, Mariotte P, Talon D, Bertrand X; ONERBA.

Antimicrob Agents Chemother. 2010 Aug;54(8):3512-5. doi: 10.1128/AAC.01646-09. Epub 2010 Jun 14.

PMID:: 20547814; [PubMed - indexed for MEDLINE]

Free PMC Article

Related citations

<< First< Prev

Page of 5

Next >Last >>

Supplemental Content

Filters: Manage Filters

41 free full-text articles in PubMed Central

Difficult-to-detect carbapenem-resistant IMP13-producing P. aeruginosa: experience feedback concerning a cluster of urinary tract infections at a surgical clinic in France. [Antimicrob Resist Infect Contr...]
Difficult-to-detect carbapenem-resistant IMP13-producing P. aeruginosa: experience feedback concerning a cluster of urinary tract infections at a surgical clinic in France.
Milan O, Debroize L, Bertrand X, Plesiat P, Valentin AS, Quentin R, Van der Mee-Marquet N. Antimicrob Resist Infect Control. 2013 Apr 4; 2(1):12. Epub 2013 Apr 4.
Unique biofilm signature, drug susceptibility and decreased virulence in Drosophila through the Pseudomonas aeruginosa two-component system PprAB. [PLoS Pathog. 2012]
Unique biofilm signature, drug susceptibility and decreased virulence in Drosophila through the Pseudomonas aeruginosa two-component system PprAB.
de Bentzmann S, Giraud C, Bernard CS, Calderon V, Ewald F, Plésiat P, Nguyen C, Grunwald D, Attree I, Jeannot K, et al. PLoS Pathog. 2012; 8(11):e1003052. Epub 2012 Nov 29.
Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting. [PLoS Pathog. 2012]
Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting.
Hocquet D, Llanes C, Thouverez M, Kulasekara HD, Bertrand X, Plésiat P, Mazel D, Miller SI. PLoS Pathog. 2012; 8(6):e1002778. Epub 2012 Jun 14.